A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant

Qiong Tang1, Dai Gong1, Xiao-Min Ye1

  • 1Department of Children Health Care Center, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, People's Republic of China.

Insights

Cardiofaciocutaneous syndrome (CFCS) typically presents with heart defects, but this case shows atypical symptoms. Genetic analysis identified novel variants, expanding the known spectrum of CFCS.

Area of Science:

  • Genetics
  • Rare Diseases
  • Dermatology

Background:

  • Cardiofaciocutaneous syndrome (CFCS) is a rare genetic disorder characterized by craniofacial dysmorphism, cardiac abnormalities, ectodermal abnormalities, psychomotor delay, intellectual disability, and short stature.
  • Approximately 300 cases of CFCS have been documented globally.

Observation:

  • This report details a patient diagnosed with CFCS exhibiting craniofacial features, skin abnormalities, intellectual disability, and short stature, but notably lacking typical cardiac malformations.
  • Genetic testing revealed three potentially harmful variants: one in MAP2K1 and two in ATP2B3 and CDC42BPB.

Findings:

  • The patient's presentation suggests an atypical manifestation of CFCS, broadening the understanding of its clinical spectrum.
  • The pathogenic significance of the identified MAP2K1, ATP2B3, and CDC42BPB variants in relation to the observed symptoms remains undetermined.

Implications:

  • This case report contributes valuable clinical reference material for cardiofaciocutaneous syndrome.
  • Further research is needed to establish the link between the identified genetic variants and the patient's specific clinical presentation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...